Table 3. Measured risk factors of the respondents (n = 249).
Variables | Men(n = 118) | 95% CI | Women (n = 131) | 95% CI | Both (n = 249) | 95% CI | P value |
---|---|---|---|---|---|---|---|
n (%) | n (%) | n (%) | |||||
History of hypertension | |||||||
Reported hypertension | 42 (35.3) | 26.7–43.9 | 42 (32.3) | 16.1–30.5 | 84 (33.7) | 27.8–39.6 | 0.05*** |
H/O taking antihypertensive medications | 42 (35.3) | 26.7–43.9 | 14 (10.8) | 5.5–16.1 | 31 (12.3) | 8.2–16.4 | 0.53*** |
Systolic blood pressure (mmHg) | |||||||
<120 | 28 (23.5) | 15.8–31.2 | 35 (26.9) | 19.3–34.5 | 63 (25.3) | 19.9–30.7 | 0.24*** |
120–139 | 60 (50.4) | 41.4–59.4 | 79 (60.8) | 52.4–69.2 | 139 (55.8) | 49.6–62.0 | |
≥140* | 31 (26.0) | 18.1–33.9 | 16 (12.3) | 6.7–17.9 | 47 (18.9) | 14.0–23.8 | 0.23** |
Mean ± SD | 116.6±16.8 | 114.3±13.9 | 115.4±15.4 | ||||
Diastolic blood pressure (mmHg) | |||||||
<80 | 22 (18.4) | 11.4–25.4 | 24 (18.4) | 11.8–25.0 | 46 (18.4) | 13.6–23.2 | |
80–89 | 77 (64.7) | 56.1–73.3 | 93 (71.5) | 63.8–79.2 | 170 (68.3) | 62.5–74.1 | 0.06*** |
≥90* | 20 (16.8) | 10.1–23.5 | 13 (10.0) | 4.9–15.1 | 33 (13.3) | 9.1–17.5 | |
Mean ± SD | 75.5±10.1 | 74.2±8.9 | 74.8±9.4 | 0.64** | |||
Newly diagnosed# Hypertension | 51 (42.9) | 27.3–33.8 | 29 (22.3) | 17.7–28.5 | 80 (32.2) | 23.9–44.6 | 0.43*** |
Confirmed Hypertension## | 93 (78.2) | 64.4–93.2 | 43 (33.1) | 28.9–44.3 | 111 (44.5) | 45.2–79.5 | 0.57*** |
Body Mass Index (BMI) | |||||||
Underweight (<18.5 kg/m2) | 4 (3.4) | 0.1–6.7 | 14 (10.8) | 5.5–16.1 | 18 (7.3) | 4.1–10.5 | |
Normal weight (18.5–24.99 kg/m2) | 93 (78.2) | 70.8–85.6 | 93 (71.5) | 63.8–79.2 | 186 (74.7) | 69.3–80.1 | 0.08*** |
Overweight (25–29.9 kg/m2) | 20 (16.8) | 10.1–23.5 | 22 (16.9) | 10.5–23.2 | 42 (16.9) | 12.2–21.6 | |
Obese (≥30 kg/m2) | 2 (1.7) | 0.0–4.0 | 1 (0.7) | 0.0–2.1 | 3 (1.2) | 0.0–2.7 | |
Mean ± SD | 22.8±2.5 | 22.3–23.2 | 22.0±3.0 | 21.4–22.5 | 22.4±2.8 | 22.0–22.7 | 0.79** |
* Stage I and II hypertension (systolic 140- ≥160 mmHg and diastolic 90- ≥100 mmHg) were merged due to insufficient number of participants in each groups
#includes those who have systolic and diastolic BP within hypertensive rages
## includes all newly diagnosed hypertensive cases and those who reported taking anti-hypertensive drugs previously
**Student t test was done
***Chi-square test was done